PCI Biotech: US patent for the vaccine technology (fimaVACC) with a new important class of adjuvants NewsKristin EivindvikMarch 26, 2020
PCI Biotech: Update on operational implications of the corona pandemic NewsKristin EivindvikMarch 25, 2020
Invitation to fourth quarter and preliminary 2019 results presentation NewsKristin EivindvikFebruary 19, 2020
PCI Biotech: US patent granted for the vaccine technology (fimaVACC) in combination with cytokines NewsKristin EivindvikJanuary 21, 2020
PCI Biotech to present Phase I fimaVACC results at ESMO Immuno-Oncology 2019 NewsKristin EivindvikDecember 12, 2019
PCI Biotech: Expansion of preclinical research collaboration agreement with AstraZeneca NewsKristin EivindvikNovember 26, 2019
PCI Biotech to present at Jefferies 2019 London Healthcare Conference NewsKristin EivindvikNovember 19, 2019
PCI Biotech is hiring a Chief Medical Officer and a Chief Business Officer NewsKristin EivindvikOctober 9, 2019
Invitation to second quarter and first half 2019 results presentation NewsKristin EivindvikAugust 20, 2019
Extension of preclinical research collaboration agreement with a top-10 large pharma company NewsKristin EivindvikJuly 22, 2019
